scholarly article | Q13442814 |
P356 | DOI | 10.1093/HMG/9.12.1771 |
P8608 | Fatcat ID | release_afwpn3b3ofgfnpfttl3wxmpope |
P698 | PubMed publication ID | 10915765 |
P2093 | author name string | Chiba-Falek O | |
Kerem B | |||
Sharon G | |||
Boss A | |||
Nissim-Rafinia M | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1771-1778 | |
P577 | publication date | 2000-07-01 | |
P1433 | published in | Human Molecular Genetics | Q2720965 |
P1476 | title | Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations | |
P478 | volume | 9 |
Q92483205 | Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing |
Q44879918 | Alternative splicing in disease and therapy |
Q46865386 | An intronic sequence mutated in flexed-tail mice regulates splicing of Smad5. |
Q37218067 | Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping |
Q36691150 | Better days are coming for Riley-Day patients. |
Q41593485 | Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA. |
Q42661342 | Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. |
Q40629721 | EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia |
Q35126189 | Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions |
Q36269320 | Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial |
Q34405099 | Genetic analysis of three genes causing isolated methylmalonic acidemia: identification of 21 novel allelic variants |
Q38818339 | Genetic medicines for CF: Hype versus reality |
Q40649754 | Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. |
Q36037679 | Molecular pathology of the CFTR locus in male infertility |
Q47873317 | New splicing mutations in propionic acidemia |
Q24291081 | Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping |
Q48228356 | Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia? |
Q44965124 | Qualitative and quantitative analysis of the effect of splicing mutations in propionic acidemia underlying non-severe phenotypes |
Q37887199 | Recommendations for the classification of diseases as CFTR-related disorders |
Q34166299 | Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation |
Q38300717 | SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer |
Q40920052 | Screening of SMAD7 in Malay patients with ventricular septal defect. |
Q34540777 | Splicing regulation as a potential genetic modifier |
Q33237932 | Spontaneous rescue from cystic fibrosis in a mouse model |
Q28567202 | StAR enhances transcription of genes encoding the mitochondrial proteases involved in its own degradation |
Q42709929 | The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis |
Q34355404 | The cystic fibrosis transmembrane conductance regulator: an intriguing protein with pleiotropic functions |
Q47228639 | The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles |
Search more.